PACB CIK: 1299130

Pacific Biosciences of California, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
58.9
FY22:
49.0
FY23:
52.8
FY24:
37.3
FY25:
45.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−210
FY22:
−307
FY23:
−334
FY24:
−474
FY25:
−554
(positive)
Change from FY21 to FY25
millions USD
FY21:
−275
FY22:
−314
FY23:
−318
FY24:
−310
FY25:
−546
(positive)
Change from FY21 to FY25
millions USD
FY21:
−181
FY22:
−314
FY23:
−307
FY24:
−310
FY25:
−546

All amounts in millions USD Data source:SEC EDGAR